Participated · Series B · Jul 2020

Genome Medical operates as an independent virtual medical practice powered by a digital health technology platform (its Genome Care DeliveryTM platform) to deliver on-demand genetic insights, clinical assessments, test ordering and personalized care plans. The company partners with health systems, providers, health plans, employers, labs and biopharma to expand access to genomic medicine. Genome Medical announced the acquisition of GeneMatters, which will operate as a wholly owned subsidiary focused on expanding genetic services to community health systems and other partners. The company plans to use proceeds from its recent financing to expand its team and further develop configurable technology solutions, physician services, test ordering capabilities and guidelines-based care plans. Headquartered in South San Francisco, Genome Medical positions itself to accelerate adoption of genomic services across health systems, research studies, health plans, employers and diagnostic labs. Genome Medical is a telegenomics technology, services and strategy company that delivers virtual genetic care through a nationwide network of genetic specialists and its Genome Care Delivery technology platform. The company provides expert virtual genetic care for individuals and their families and helps health care providers and patients navigate genetics to understand disease risk, accelerate diagnosis, inform treatment decisions and lower cost of care. Its solutions are utilized by health systems, hospitals, payors, providers and employers, and the company also serves patients directly and accepts self-referrals. Led by CEO and co-founder Lisa Alderson, Genome Medical focuses on applying genomic-based medicine across clinical settings. The company intends to use new funding to accelerate development of its Genome Care Delivery platform for cancer, reproductive health and pharmacogenomics. Since 2016 the company has raised a total of $60M, including the latest round. Genome Medical operates a cloud-based genomic care delivery platform that provides on-demand access to genetic experts for virtual visits, provider-to-provider consults, genetic wellness assessment, and screening for population health management. The company partners with hospitals, health systems, payers, providers, and employers to make genomic medicine accessible to patients nationwide. Led by co-founder and CEO Lisa Alderson, Genome Medical is based in South San Francisco, California. The company plans to scale its team of clinical genomics specialists and accelerate development of its proprietary genomic care delivery platform using the new funding. Financially, Genome Medical has raised a total of $46M since its founding in 2016, including the current Series B. The new capital is intended to expand service delivery and product development across its healthcare and employer customers. Genome Medical operates a telegenomics platform that connects a network of clinical genetics experts with patients and clinicians to provide genetic counseling and physician services. The company delivers genetic counseling in all 50 states and physician services in 30 states, covering nearly three-quarters of the U.S. population. It accepts insurance billing, institutional billing, and direct patient payment. Genome Medical plans to expand all services nationwide in 2018 and to deepen clinical offerings in cancer genetics, cardiovascular genetics, reproductive health and proactive health. The company was co-founded in 2016 and is headquartered in San Francisco. It has raised more than $23 million in financing to date. Genome Medical operates a telehealth platform that connects patients with genetic counselors, geneticists, or contracted specialists for phone or video consultations. The service is designed to increase access and reduce wait times, offering next-day scheduling and working toward same-day appointment capabilities. Consultations currently cost $149 for a video visit, and the company is pursuing insurance coverage. Genome Medical offers both pre-test “proactive health” counseling and post-test consultations that include a detailed clinical action plan. The company has formed partnerships (including Good Start Genetics) and is building out a team of doctors to integrate genetic testing into clinical care. It was founded by CEO Lisa Alderson with Randy Scott and Harvard Medical School geneticist Robert Green and has raised $12 million in funding from institutional investors.

Participated · Seed · Apr 2020

Cadence operates a securitization platform on top of the Ethereum blockchain that helps originators package and sell asset-backed securities while giving investors improved, verifiable asset performance data. The platform generates revenue from transaction fees and hosting performance data for underlying loans. To date the company has structured $88 million in notes across 76 offerings and 12 originators on its retail platform, and it completed a $40 million whole-business securitization for FAT Brands that cut that borrower’s interest costs by $2 million. Cadence’s public leaderboard shows its largest originators include Sellers Funding (~$23M) and Wall Street Funding (~$26M), and the company said it was the 21st largest structuring agent in the U.S. in 2020 so far. Longer term, the company plans to transition to a primarily SaaS model for originators and buyers to increase efficiency and align incentives across counterparties.

Participated · Series A · Feb 2017

HealthReveal provides a next‑generation cloud-based clinical analytics solution that integrates multiple real-time streams of clinical, operational and biometric data to monitor patient physiology and care. The platform uses evidence-based medicine as a foundation for machine learning to detect deviations from guideline-directed care and suggest highly personalized interventions. HealthReveal partners with providers, payers and employers to enable earlier detection of potentially life‑threatening issues and to intervene before adverse events occur. The company says it will apply additional machine‑learning techniques and leverage the Internet of Things to continually monitor at‑risk patients. Its stated mission is to preempt the avoidable consequences of chronic disease and ensure guideline-directed medical therapy is delivered. The company notes that patients with chronic disease receive guideline-directed therapy approximately 50% of the time and that chronic disease represents roughly 86% of annual healthcare costs.

Participated · Series A · Mar 2016

Pathmatics operates a marketing intelligence platform that gives users visibility into digital ad performance across display, social, video, mobile and native advertising. The product aggregates creative, spend and impression data and maps the path from publisher to viewer, enabling brands and agencies to optimize media and marketing decisions. Clients use the platform to minimize wasted budget, position marketing and anticipate competitors' moves. Pathmatics' data powers Nielsen’s digital ad intelligence offering and Kantar Media’s Facebook intelligence, and is used by agencies including Mindshare, Mediacom and Possible. The company was founded in 2011 by Gabe Gottlieb and is based in Santa Monica, CA. In October 2018 Pathmatics received a $3M strategic investment from Mintel and SPH Ventures, which joined existing backers. Pathmatics provides PathSource™, a patent-pending technology that analyzes digital advertising activity and delivers real-time, actionable intelligence to advertisers, agencies, publishers and ad tech providers. The company was founded in 2010 by Gabe Gottlieb and is based in Santa Monica, California, with an office in New York. Pathmatics sells intelligence to participants across the online advertising ecosystem and continues to develop its proprietary technology. Management intends to use new funding to pursue continued global expansion and to further invest in its technology. The article does not disclose revenue or user metrics.

Participated · Seed · Feb 2015

Fabric is a mobile app that lets users build "want-to" lists for entertainment and lifestyle activities by browsing hundreds of curated packs covering movies, TV, music and travel. It employs a patent-pending four-directional swipe interface and an intelligent compatibility algorithm to surface personalized and community-based recommendations and ordering. Fabric links lists to commerce partners including iTunes, Amazon, Google Play and Fandango to make items actionable and facilitate purchases. The product already hosts celebrity-curated lists and the company says it is rapidly expanding coverage into additional categories. Fabric launched on the Apple App Store and emphasizes connecting points of passion with points of purchase. The company is currently closing a $1.5M seed round.